Champions Oncology Inc 's ability to collect accounts receivable sequentially worsen to 4.49, indicating more challenging environment then in the third quarter 2026, but still, it is a far cry from any concerns. Champions Oncology Inc 's Accounts Receivable average collection period in the Apr 30 2026 quarter, has increased to 81 days, from 68 days, in the Jan 31 2026 quarter.

If we take a look into Healthcare sector 16 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Apr 30 2026 from 181 to 263.

What is Receivable Turnover Ratio?
What is Champions Oncology Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CSBR Receivables Turnover Ratio	(Apr 30 2026) IV. Quarter	(Jan 31 2026) III. Quarter	(Oct 31 2025) II. Quarter	(Jul 31 2025) I. Quarter	(Apr 30 2025) IV. Quarter
Y / Y Receivable Change	84.32 %	17.93 %	10.21 %	4.89 %	17.93 %
Y / Y Revenue Change	11.99 %	-2.82 %	11.46 %	-0.47 %	-11.76 %
Receivable Turnover Ratio (TTM)	4.49	5.33	5.59	5.59	5.66
CSBR's Total Ranking	# 263	# 181	# 195	# 181	# 172
Accounts Receivable average collection period days	81	68	65	65	65
Seq. Receivable Change	84.32 %	-2.64 %	21.8 %	-15.67 %	17.93 %
Seq. Revenue Change	-16.44 %	10.14 %	7.43 %	13.27 %	-27.49 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 2
Healthcare Sector	# 17
Overall Market	# 263

Receivable Turnover Ratio Statistics
High	Average	Low
2.85	1.84	0.89
(Apr 30 2019)		(Oct 31 2013)

CSBR Company Profile • Back to CSBR Efficiency Comparisons • Compare CSBR Receivables Turnover Ratio to its Competitors

Financial Statements
Champions Oncology Inc 's Accounts Receivable	$ 21 Millions	Visit CSBR's Balance sheet
Champions Oncology Inc 's Sales TTM	$ 59 Millions	Visit CSBR's Income Statement
Sources of CSBR's Revenues		Visit CSBR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CSBR's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CSBR's Growth Rates	CSBR's Roa	CSBR's Inventory Turnover Ratio	CSBR's Dividend Comparisons
CSBR's Profitability Ratios	CSBR's Roi	CSBR's Asset Turnover Ratio	CSBR's Dividend Growth
CSBR's Valuation Ratios	CSBR's Roe	CSBR's Financial Strength Ratios	CSBR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Apr 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Apr 30 2026	Receivable at quarter ending Apr 30 2026
Beta Bionics Inc	7.89	$ 110.003 Millions	$ 13.950 Millions
Acadia Pharmaceuticals Inc	7.88	$ 1,095.250 Millions	$ 138.935 Millions
Zymeworks Inc	7.87	$ 81.263 Millions	$ 10.324 Millions
Neuroone Medical Technologies Corp	7.85	$ 9.721 Millions	$ 1.239 Millions
Neuronetics Inc	7.82	$ 150.724 Millions	$ 19.272 Millions
Exelixis Inc	7.80	$ 2,375.491 Millions	$ 304.486 Millions
Idexx Laboratories Inc	7.79	$ 4,445.939 Millions	$ 570.842 Millions
Inspire Medical Systems inc	7.78	$ 915.060 Millions	$ 117.614 Millions
Sonoma Pharmaceuticals Inc	7.76	$ 19.529 Millions	$ 2.516 Millions
Myomo Inc	7.75	$ 41.180 Millions	$ 5.317 Millions
Pacs Group Inc	7.71	$ 5,432.276 Millions	$ 704.948 Millions
Acadia Healthcare Company Inc	7.70	$ 3,371.066 Millions	$ 437.934 Millions
Plus Therapeutics Inc	7.70	$ 5.182 Millions	$ 0.673 Millions
Quest Diagnostics Inc	7.69	$ 11,278.000 Millions	$ 1,467.500 Millions
Uniqure N v	7.68	$ 18.093 Millions	$ 2.356 Millions
Natera Inc	7.64	$ 2,500.927 Millions	$ 327.432 Millions
Cannapharmarx Inc	7.57	$ 1.654 Millions	$ 0.219 Millions
Foxo Technologies Inc	7.56	$ 27.325 Millions	$ 3.615 Millions
Omada Health Inc	7.55	$ 281.916 Millions	$ 37.326 Millions
Tela Bio Inc	7.55	$ 80.349 Millions	$ 10.643 Millions
Novocure Limited	7.54	$ 674.414 Millions	$ 89.464 Millions
Intuitive Surgical Inc	7.49	$ 10,582.100 Millions	$ 1,412.950 Millions
Cue Biopharma Inc	7.48	$ 32.731 Millions	$ 4.378 Millions
Maravai Lifesciences Holdings Inc	7.46	$ 203.841 Millions	$ 27.333 Millions
Travere Therapeutics Inc	7.42	$ 536.195 Millions	$ 72.285 Millions
Lemaitre Vascular Inc	7.42	$ 256.515 Millions	$ 34.583 Millions
Twist Bioscience Corporation	7.41	$ 409.479 Millions	$ 55.272 Millions
Quidelortho Corp	7.39	$ 2,657.200 Millions	$ 359.600 Millions
Koru Medical Systems Inc	7.38	$ 43.257 Millions	$ 5.863 Millions
Si bone inc	7.38	$ 206.128 Millions	$ 27.945 Millions

Date modified: 2026-07-28T16:08:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.